German firm tests 'double chin' drug

January 10, 2011

German drugs giant Bayer said Monday it had launched tests into an injectable drug to combat the fat deposits that lead to the dreaded "double chin."

Bayer said in a statement it was conducting clinical trials into ATX-101, an injectable "for the reduction of localised under the chin (submental fat)."

The firm is testing some 720 people in 64 centres in Britain, France, Germany, Belgium, Spain and Italy with a view to launching a product in Europe, Asia and South America in 2014.

Jean-Paul Ortonne, a French involved in the trials, said: "There is a huge demand for a safe, effective and approved injectable treatment for localised fat reduction."

The tests are a step towards "a well-studied, clinically-proven treatment to reduce localised submental fat without surgery," he added.

Yvonne Moeller, a Bayer spokeswoman, described the procedure as "something like a tattoo."

Between 40 and 70 tiny injections are administered into the over several sessions, with the amount depending on the size of the double chin and the person, she told AFP.

"You would hope to see noticeable results after about 16 weeks," she added.

Related Stories

Recommended for you

Opioid addiction treatment behind bars reduced post-incarceration overdose deaths in RI

February 14, 2018
A treatment program for opioid addiction launched by the Rhode Island Department of Corrections was associated with a significant drop in post-incarceration drug overdose deaths and contributed to an overall drop in overdose ...

Heroin vaccine blocks lethal overdose

February 14, 2018
Scientists at The Scripps Research Institute (TSRI) have achieved a major milestone toward designing a safe and effective vaccine to both treat heroin addiction and block lethal overdose of the drug. Their research, published ...

Study shows NIH spent >$100 billion on basic science for new medicines

February 12, 2018
Federally funded research contributed to the science underlying all new medicines approved by the FDA over the past six years, according to a new study by Bentley University.

Opioid use increases risk of serious infections

February 12, 2018
Opioid users have a significantly increased risk of infections severe enough to require treatment at the hospital, such as pneumonia and meningitis, as compared to people who don't use opioids.

Placebo pills prescribed honestly help cancer survivors manage symptoms

February 9, 2018
Long after cancer treatment ends, many continue to deal with one particular symptom that refuses to go away: fatigue. In a new study, researchers at the University of Alabama at Birmingham and Harvard Medical School have ...

Multinational companies continue to produce unregulated antibiotics in India

February 5, 2018
Millions of unapproved antibiotics are being sold in India, according to a new study by researchers at Queen Mary University of London and Newcastle University.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

geokstr
1 / 5 (1) Jan 10, 2011
Doctors in Beverly Hills will form a partnership to buy out the patent for this drug. After all, they've already invented a highly lucrative fix for this self-image-threatening condition.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.